MedPage Today on MSN
Dual GIP/GLP-1 drug linked to reduced diabetic retinopathy incidence
However, concerns about the impact of rapid glycemic control on diabetic retinopathy risk ...
COPENHAGEN (Reuters) - Novo Nordisk plans to invest up to 20 billion Danish crowns ($3.65 billion) on developing diabetes tablets intended to replace traditional insulin injections, it said on Monday.
A lab study in donated human pancreatic islets found that chronic exposure to glibenclamide (a sulphonylurea) reduced glucose responsive insulin release and increased beta cell stress and cell death ...
Verywell Health on MSN
A complete guide to type 1 diabetes medications
Medically reviewed by Mary Choy, PharmD Key Takeaways Insulin is needed to manage your blood sugar levels if you have type 1 diabetes. Insulin can be administered through a syringe, pen, pump, or ...
A world-first clinical trial has found that baricitinib, a drug commonly prescribed for rheumatoid arthritis, preserved the pancreatic cells’ ability to produce their own insulin and slowed the ...
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results